Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT04551131Phase 1/2Active Not Recruiting
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
Hemophagocytic Lymphohistiocytosis
StudychairStart date: 2021-07-13
NCT03050268Recruiting
Familial Investigations of Childhood Cancer Predisposition
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
PrincipalinvestigatorStart date: 2017-04-06
NCT02530658Recruiting
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Solid, Liquid, Central Nervous System Tumors
PrincipalinvestigatorStart date: 2015-08-28

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Melissa Hines, MD

St. Jude Children's Research Hospital

Related
1 trials

Shared therapeutic areas:

Lymphohistiocytosis, Hemophagocytic

Worked with same sponsors:

Cures Within ReachIncyte Corporation+2 more
Collaborated on 1 trial
Similarity Score14%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neurofibromatosis 1GISTMultiple Endocrine Neoplasia Type 2a+2 more
Similarity Score3%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinHodgkin DiseaseNeuroblastoma+1 more
Similarity Score3%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Acute LeukemiaHodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score2%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

NeuroblastomaHodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score2%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinNeuroblastoma
Similarity Score1%

Ana-Maria Vranceanu, PhD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Neurofibromatosis 2Neurofibromatosis 1
Similarity Score1%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Cancer of PancreasAdrenocortical Carcinoma
Similarity Score1%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Acute LeukemiaLymphoma, Non-Hodgkin
Similarity Score1%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

NeuroblastomaRhabdomyosarcoma
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04551131Phase 1/2StudyChair

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis
Active Not Recruiting
NCT03050268PrincipalInvestigator

Familial Investigations of Childhood Cancer Predisposition

Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
Recruiting
NCT02530658PrincipalInvestigator

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Solid, Liquid, Central Nervous System Tumors
Recruiting

All 3 trials loaded